芒果视频下载

網站分(fen)類
新開河 康美藥業股份有限(xian)公(gong)司
買購網百度權重PR8,與企業共鑄輝煌
免費注冊,綁定即可
  • 在線管理品(pin)牌資(zi)料,及時更新品(pin)牌信息
  • 發布品牌招(zhao)商信(xin)息,吸引經銷商代理
  • 發(fa)布網店、產品信(xin)息,增加交易機會(hui)
  • 發布品牌(pai)資訊、軟文,增加宣傳渠道(dao)
品牌介紹

成立于1997年,較早布局中醫藥全產業,以中藥飲片為核心,以智慧藥房為抓手,打造大健康+大平臺+大數據+大服務體系

康(kang)美(mei)藥(yao)(yao)業股份有限(xian)公(gong)司(600518)成立于(yu)1997年,于(yu)2001年在上(shang)交所上(shang)市。公(gong)司秉承“心(xin)懷蒼生、大(da)愛無疆(jiang)”的核(he)心(xin)價(jia)值觀和“用(yong)愛感動世(shi)界、用(yong)心(xin)經營(ying)(ying)健(jian)(jian)康(kang)”的經營(ying)(ying)理(li)念(nian),在國家振(zhen)興中醫(yi)藥(yao)(yao)事業戰略(lve)指(zhi)引(yin)下,布(bu)局(ju)中醫(yi)藥(yao)(yao)全產(chan)業鏈,以中藥(yao)(yao)飲(yin)片為(wei)核(he)心(xin),以智(zhi)慧(hui)藥(yao)(yao)房為(wei)抓手(shou),打造“大(da)健(jian)(jian)康(kang)+大(da)平(ping)臺+大(da)數據+大(da)服務(wu)(wu)”體系(xi),成為(wei)中醫(yi)藥(yao)(yao)全產(chan)業鏈精準服務(wu)(wu)型“智(zhi)慧(hui)+”大(da)健(jian)(jian)康(kang)產(chan)業上(shang)市企業、國家高新技(ji)術企業。

康(kang)(kang)美(mei)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)業(ye)(ye)(ye)上(shang)至(zhi)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)種(zhong)植、藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)交(jiao)易(yi),下至(zhi)生產開發、終端銷售(shou),已基(ji)本貫穿中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)產業(ye)(ye)(ye)鏈(lian)的(de)上(shang)、中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)、下游(you)產業(ye)(ye)(ye),業(ye)(ye)(ye)務(wu)滲透中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)全(quan)(quan)(quan)產業(ye)(ye)(ye)鏈(lian)的(de)各個(ge)(ge)關鍵環節,有效地(di)(di)整合全(quan)(quan)(quan)產業(ye)(ye)(ye)鏈(lian)資源。公司先后在(zai)全(quan)(quan)(quan)國(guo)(guo)(guo)(guo)各地(di)(di)投資建立140多家(jia)(jia)(jia)(jia)涵蓋藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)種(zhong)植、中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)交(jiao)易(yi)市場、現代物(wu)流中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)心和(he)(he)產業(ye)(ye)(ye)基(ji)地(di)(di)等(deng)(deng)業(ye)(ye)(ye)務(wu)的(de)企(qi)(qi)業(ye)(ye)(ye),管(guan)理的(de)交(jiao)易(yi)市場交(jiao)易(yi)規模占全(quan)(quan)(quan)國(guo)(guo)(guo)(guo)的(de)60%以(yi)(yi)(yi)上(shang),做出(chu)(chu)了多個(ge)(ge)方(fang)面的(de)國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)標(biao)(biao)(biao)準(zhun)(zhun):制(zhi)(zhi)(zhi)定中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)飲片(pian)(pian)國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)標(biao)(biao)(biao)準(zhun)(zhun)以(yi)(yi)(yi)及生產管(guan)理GMP、小包裝、色標(biao)(biao)(biao)管(guan)理、炮(pao)制(zhi)(zhi)(zhi)等(deng)(deng)國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)標(biao)(biao)(biao)準(zhun)(zhun)。參(can)(can)與國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)商(shang)務(wu)部中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)等(deng)(deng)級分類(lei)標(biao)(biao)(biao)準(zhun)(zhun)制(zhi)(zhi)(zhi)訂。承(cheng)擔(dan)編(bian)制(zhi)(zhi)(zhi)和(he)(he)運營(ying)國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)發改(gai)委(wei)批(pi)準(zhun)(zhun)、授權發布的(de)全(quan)(quan)(quan)國(guo)(guo)(guo)(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)價(jia)格指數——康(kang)(kang)美(mei)·中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)(guo)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)價(jia)格指數。推(tui)出(chu)(chu)“實體與虛擬市場相結合”的(de)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)大(da)宗現貨交(jiao)易(yi)平臺(tai),開創中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)材(cai)交(jiao)易(yi)新模式。承(cheng)擔(dan)編(bian)制(zhi)(zhi)(zhi)700多項(xiang)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)編(bian)碼的(de)國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)標(biao)(biao)(biao)準(zhun)(zhun),助力實施(shi)統一的(de)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)、中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)方(fang)劑、中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)供應鏈(lian)編(bian)碼體系(xi)、成為(wei)國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)信息化(hua)(hua)醫(yi)(yi)療機構(gou)服(fu)務(wu)平臺(tai)試點(dian)單位(wei),康(kang)(kang)美(mei)智慧(hui)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)房被列為(wei)國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)醫(yi)(yi)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)服(fu)務(wu)標(biao)(biao)(biao)準(zhun)(zhun)化(hua)(hua)研(yan)究基(ji)地(di)(di),打造了互聯網(wang)時代的(de)就醫(yi)(yi)用(yong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)新模式。是承(cheng)擔(dan)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)典會動物(wu)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)飲片(pian)(pian)炮(pao)制(zhi)(zhi)(zhi)規范(fan)項(xiang)目企(qi)(qi)業(ye)(ye)(ye),獲(huo)(huo)批(pi)國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)民營(ying)網(wang)絡醫(yi)(yi)院(yuan)資質。組建了由6位(wei)中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)科院(yuan)、工程院(yuan)院(yuan)士(shi)及眾多國(guo)(guo)(guo)(guo)醫(yi)(yi)大(da)師組成的(de)專家(jia)(jia)(jia)(jia)委(wei)員會,在(zai)廣州和(he)(he)北京設(she)立康(kang)(kang)美(mei)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)物(wu)研(yan)究院(yuan),擁(yong)有“國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)企(qi)(qi)業(ye)(ye)(ye)技術中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)心”等(deng)(deng)20多個(ge)(ge)國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)及省部級研(yan)發平臺(tai)和(he)(he)14個(ge)(ge)自主研(yan)發平臺(tai),已開展中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)國(guo)(guo)(guo)(guo)際化(hua)(hua)、中(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)(zhong)藥(yao)(yao)(yao)(yao)(yao)(yao)(yao)標(biao)(biao)(biao)準(zhun)(zhun)化(hua)(hua)等(deng)(deng)國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)及省部級重大(da)項(xiang)目近百個(ge)(ge),主持和(he)(he)參(can)(can)加制(zhi)(zhi)(zhi)定國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)、行業(ye)(ye)(ye)標(biao)(biao)(biao)準(zhun)(zhun)數十(shi)項(xiang),獲(huo)(huo)批(pi)國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)或國(guo)(guo)(guo)(guo)際組織認(ren)證的(de)實驗室3個(ge)(ge),獲(huo)(huo)得省級及以(yi)(yi)(yi)上(shang)科技獎勵15項(xiang)。擁(yong)有發明專利(li)、實用(yong)新型專利(li)、外觀設(she)計專利(li)、軟件著作權等(deng)(deng)知(zhi)識(shi)產權達620余項(xiang),是國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)技術創新示(shi)(shi)范(fan)企(qi)(qi)業(ye)(ye)(ye)和(he)(he)國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)智能制(zhi)(zhi)(zhi)造試點(dian)示(shi)(shi)范(fan)企(qi)(qi)業(ye)(ye)(ye)、國(guo)(guo)(guo)(guo)家(jia)(jia)(jia)(jia)知(zhi)識(shi)產權優勢企(qi)(qi)業(ye)(ye)(ye)。

公(gong)(gong)司在全(quan)國(guo)建(jian)立了(le)(le)17個中藥(yao)飲片(pian)和醫(yi)藥(yao)現代化生產基(ji)地,與(yu)超過2000家(jia)(jia)醫(yi)療機構、20萬家(jia)(jia)藥(yao)店建(jian)立了(le)(le)合作關(guan)系(xi),年門(men)診總(zong)量達到2.5億人(ren)次(ci)以上,投資(zi)管理康(kang)美(mei)醫(yi)院(yuan)(yuan)(yuan)、康(kang)美(mei)梅(mei)河口中心(xin)醫(yi)院(yuan)(yuan)(yuan)、康(kang)美(mei)開(kai)原市中心(xin)醫(yi)院(yuan)(yuan)(yuan)、康(kang)美(mei)通城人(ren)民(min)醫(yi)院(yuan)(yuan)(yuan)、康(kang)美(mei)柳河中心(xin)醫(yi)院(yuan)(yuan)(yuan)等多家(jia)(jia)公(gong)(gong)立醫(yi)院(yuan)(yuan)(yuan),在100多家(jia)(jia)公(gong)(gong)立醫(yi)院(yuan)(yuan)(yuan)開(kai)展醫(yi)藥(yao)物流延伸配送服務(wu)。

公(gong)司以(yi)國(guo)(guo)家中(zhong)醫(yi)(yi)(yi)藥(yao)(yao)(yao)管(guan)理局信(xin)(xin)息(xi)化醫(yi)(yi)(yi)療服務(wu)平(ping)臺(tai)試點單(dan)位(wei)為(wei)契機,在中(zhong)醫(yi)(yi)(yi)藥(yao)(yao)(yao)行(xing)業(ye)(ye)把互聯網深度布局全產(chan)業(ye)(ye)鏈中(zhong),以(yi)中(zhong)藥(yao)(yao)(yao)飲片為(wei)核心,以(yi)智慧藥(yao)(yao)(yao)房為(wei)抓手,圍(wei)繞“大(da)健(jian)康+大(da)平(ping)臺(tai)+大(da)數據+大(da)服務(wu)”體系(xi),以(yi)全產(chan)業(ye)(ye)鏈資源優勢,積極探索(suo)中(zhong)醫(yi)(yi)(yi)藥(yao)(yao)(yao)工業(ye)(ye)智能制造(zao)4.0,打造(zao)“智慧藥(yao)(yao)(yao)房”模式,國(guo)(guo)務(wu)院辦公(gong)廳、國(guo)(guo)家衛(wei)健(jian)委(wei)、國(guo)(guo)家中(zhong)醫(yi)(yi)(yi)藥(yao)(yao)(yao)管(guan)理局先后發文(wen),明(ming)確“鼓勵有條件的醫(yi)(yi)(yi)療機構推進‘智慧藥(yao)(yao)(yao)房’建設(she),實現處方(fang)系(xi)統(tong)(tong)與藥(yao)(yao)(yao)房配方(fang)系(xi)統(tong)(tong)無(wu)縫對接。”“智慧藥(yao)(yao)(yao)房”模式上升為(wei)行(xing)業(ye)(ye)標準,為(wei)患者提供了“一站式”藥(yao)(yao)(yao)事服務(wu),實現了“讓(rang)信(xin)(xin)息(xi)多(duo)跑(pao)路,讓(rang)群眾少跑(pao)腿”。

康美(mei)藥(yao)(yao)業(ye)(ye)將(jiang)以(yi)“經營有界、突出主業(ye)(ye)”為(wei)指(zhi)導思想,圍(wei)繞“聚焦核心業(ye)(ye)務(wu)、提(ti)高核心競爭(zheng)力”的工作方針,明確(que)以(yi)中藥(yao)(yao)飲片及其(qi)制品為(wei)核心業(ye)(ye)務(wu),通過有機(ji)整合公司的產(chan)業(ye)(ye)布局優(you)(you)勢(shi)、線(xian)上線(xian)下互相(xiang)強化的采購(gou)優(you)(you)勢(shi)、研發制成(cheng)與質(zhi)管優(you)(you)勢(shi)、營銷服務(wu)優(you)(you)勢(shi),成(cheng)為(wei)具(ju)備中醫藥(yao)(yao)全產(chan)業(ye)(ye)鏈動態整合和規范經營能力的標(biao)桿企業(ye)(ye)。

本品牌介紹頁由 CN106910 整理匯編上傳,最近更新時間:2021-12-01 評論 糾錯/刪除
品牌投票

品牌榜單

所屬行業 品牌榜 榜單
人參 查看榜單

品牌投票

所屬行業 行業得票數 趨勢 投票
人參 4,949 投票
本頁面投票數據有延遲,以點擊行業名稱去到的投票頁面展示為準
相關品牌(1個)
  • 康美藥業KANGMEI
    0663-2917777,400-6600-518,成立于1997年,以中藥飲片為核心,打造大健康+大平臺+大數據+大服務體系,中醫藥全產業鏈精準服務型智慧+大健康產業企業
    • 網店類型品牌旗艦(jian)店
    • 推薦指數  41240
    • 網店類型京東自(zi)營(ying)店
    • 推薦指數  13343
    • 網店類型京東旗艦(jian)店
    • 推薦指數  3162
  • 1
    ¥58
    月銷:50+
  • 2
    ¥27
    月銷:1+
  • 3
    ¥230
    月銷:8+
發表評論
您還未登錄,依《網絡安全法》相關要求,請您登錄賬戶后再提交發布信息。點擊登錄>>如您還未注冊,可,感謝您的理解及支持!
最新評(ping)論
康美**業股份有限公司的會員,應該能看見下面的人才對,我們報單都不知道給報到哪里去了
網友 (36.48.*.*)  09-18 18:39
你就知道了
網友 (36.48.*.*)  09-18 18:37
康美這個大平臺,值得依賴,在這個大平臺上,得到了健康,還能得到財富,
網友 (36.48.*.*)  09-18 17:38
加(jia)載更(geng)多
網站提醒和聲明
免責聲明(ming): 本站為會員提(ti)供信(xin)(xin)息(xi)(xi)存儲(chu)空(kong)間服務,由于更新時(shi)間等問(wen)題,可能存在(zai)信(xin)(xin)息(xi)(xi)錯誤的(de)情況(kuang),本站不保證所提(ti)供信(xin)(xin)息(xi)(xi)的(de)準(zhun)確性(xing)、完整(zheng)性(xing)、合法性(xing)和真實性(xing),請(qing)以品牌(pai)企業(ye)官網信(xin)(xin)息(xi)(xi)為準(zhun)。如有侵權(quan)、錯誤信(xin)(xin)息(xi)(xi)或任(ren)何問(wen)題,請(qing)及時(shi)聯(lian)系我們(men),我們(men)將在(zai)第(di)一時(shi)間刪除或更正(zheng)。 版權聲明>> 修改>> 申請刪除>> 網頁(ye)上相關信(xin)息的知識產權歸網站方所有(you)(包括但不(bu)(bu)限于文字、圖(tu)片、圖(tu)表(biao)、著作權、商(shang)(shang)標(biao)權、為用(yong)戶提(ti)供(gong)的商(shang)(shang)業信(xin)息等),非經許可不(bu)(bu)得抄(chao)襲(xi)或(huo)使用(yong),本(ben)(ben)站不(bu)(bu)生產產品(pin),不(bu)(bu)提(ti)供(gong)產品(pin)銷售服務,不(bu)(bu)對任(ren)何(he)人(ren)的任(ren)何(he)交易承擔任(ren)何(he)責任(ren),不(bu)(bu)代(dai)理(li),不(bu)(bu)招商(shang)(shang),不(bu)(bu)提(ti)供(gong)中介服務。本(ben)(ben)頁(ye)面內容(rong)不(bu)(bu)代(dai)表(biao)本(ben)(ben)站支(zhi)持投資購買的觀點(dian)或(huo)意見,頁(ye)面信(xin)息僅供(gong)參考(kao)和借鑒。
提交說明: 查看提交幫助>> 注冊登錄>>
歡迎您來到十大品牌CNPP
登錄
頁面相關分類
熱門模塊
已有3844581個品牌入駐 更新518002個招商信息 已發布1579032個代理需求 已有1325409條品牌點贊